| Joshua Wynne, MD | |
|
801 Broadway N, Fargo, ND 58102-3641 | |
| (701) 234-2371 | |
| (701) 234-3434 |
| Full Name | Joshua Wynne |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 53 Years |
| Location | 801 Broadway N, Fargo, North Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376565960 | NPI | - | NPPES |
| 373643100 | Medicaid | MN | |
| 13308 | Medicaid | ND |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 9903 (North Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sanford Medical Center Fargo | Fargo, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sanford Medical Center Fargo | 8426967803 | 1094 |
| Sanford Clinic North | 4284546151 | 84 |
| Sanford Medical Center Fargo | 8426967803 | 1094 |
News Archive
While American paediatricians warn sleep deprivation can stack the deck against teenagers, a new study from Taylor & Francis reveals youth's irritability and laziness aren't down to attitude problems but lack of sleep.
Affymetrix, Inc. (NASDAQ: AFFX) announces the introduction of the Axiom® 384HT genotyping format, a breakthrough cost-effective, high-throughput format for genotyping in which 384 samples are simultaneously processed with 384 discrete microarrays in a microplate format analyzing up to 50,000 SNPs per sample.
Hepatitis E virus infection is once again in the spotlight, with two studies presented today at The International Liver Congress 2018 in Paris, France challenging the ideas that HEV infections are benign and self-limiting, and that blood-borne transmission is a rare event.
Bioniche Life Sciences Inc. has provided an update on its Phase III clinical program evaluating Urocidin(TM) in the treatment of bladder cancer. On March 31st, the Company announced that recruitment had been completed in its initial Phase III registration trial evaluating Urocidin in the treatment of non-muscle-invasive bladder cancer that is refractory (unresponsive) to the current standard immunotherapy - Bacillus Calmette-Guérin (BCG).
An estimated 600 experts on nanobiotechnology-a science that develops tools and machinery at the scale of one-billionth of a meter-are expected to attend the second annual Johns Hopkins NanoBio Symposium, May 1-2, 2008.
› Verified 6 days ago
| Entity Name | Sanford Clinic North |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942241351 PECOS PAC ID: 4284546151 Enrollment ID: O20031112000221 |
News Archive
While American paediatricians warn sleep deprivation can stack the deck against teenagers, a new study from Taylor & Francis reveals youth's irritability and laziness aren't down to attitude problems but lack of sleep.
Affymetrix, Inc. (NASDAQ: AFFX) announces the introduction of the Axiom® 384HT genotyping format, a breakthrough cost-effective, high-throughput format for genotyping in which 384 samples are simultaneously processed with 384 discrete microarrays in a microplate format analyzing up to 50,000 SNPs per sample.
Hepatitis E virus infection is once again in the spotlight, with two studies presented today at The International Liver Congress 2018 in Paris, France challenging the ideas that HEV infections are benign and self-limiting, and that blood-borne transmission is a rare event.
Bioniche Life Sciences Inc. has provided an update on its Phase III clinical program evaluating Urocidin(TM) in the treatment of bladder cancer. On March 31st, the Company announced that recruitment had been completed in its initial Phase III registration trial evaluating Urocidin in the treatment of non-muscle-invasive bladder cancer that is refractory (unresponsive) to the current standard immunotherapy - Bacillus Calmette-Guérin (BCG).
An estimated 600 experts on nanobiotechnology-a science that develops tools and machinery at the scale of one-billionth of a meter-are expected to attend the second annual Johns Hopkins NanoBio Symposium, May 1-2, 2008.
› Verified 6 days ago
| Entity Name | Sanford Medical Center Fargo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184917924 PECOS PAC ID: 8426967803 Enrollment ID: O20110331000495 |
News Archive
While American paediatricians warn sleep deprivation can stack the deck against teenagers, a new study from Taylor & Francis reveals youth's irritability and laziness aren't down to attitude problems but lack of sleep.
Affymetrix, Inc. (NASDAQ: AFFX) announces the introduction of the Axiom® 384HT genotyping format, a breakthrough cost-effective, high-throughput format for genotyping in which 384 samples are simultaneously processed with 384 discrete microarrays in a microplate format analyzing up to 50,000 SNPs per sample.
Hepatitis E virus infection is once again in the spotlight, with two studies presented today at The International Liver Congress 2018 in Paris, France challenging the ideas that HEV infections are benign and self-limiting, and that blood-borne transmission is a rare event.
Bioniche Life Sciences Inc. has provided an update on its Phase III clinical program evaluating Urocidin(TM) in the treatment of bladder cancer. On March 31st, the Company announced that recruitment had been completed in its initial Phase III registration trial evaluating Urocidin in the treatment of non-muscle-invasive bladder cancer that is refractory (unresponsive) to the current standard immunotherapy - Bacillus Calmette-Guérin (BCG).
An estimated 600 experts on nanobiotechnology-a science that develops tools and machinery at the scale of one-billionth of a meter-are expected to attend the second annual Johns Hopkins NanoBio Symposium, May 1-2, 2008.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joshua Wynne, MD 801 Broadway N, Fargo, ND 58102-3641 Ph: (701) 234-2371 | Joshua Wynne, MD 801 Broadway N, Fargo, ND 58102-3641 Ph: (701) 234-2371 |
News Archive
While American paediatricians warn sleep deprivation can stack the deck against teenagers, a new study from Taylor & Francis reveals youth's irritability and laziness aren't down to attitude problems but lack of sleep.
Affymetrix, Inc. (NASDAQ: AFFX) announces the introduction of the Axiom® 384HT genotyping format, a breakthrough cost-effective, high-throughput format for genotyping in which 384 samples are simultaneously processed with 384 discrete microarrays in a microplate format analyzing up to 50,000 SNPs per sample.
Hepatitis E virus infection is once again in the spotlight, with two studies presented today at The International Liver Congress 2018 in Paris, France challenging the ideas that HEV infections are benign and self-limiting, and that blood-borne transmission is a rare event.
Bioniche Life Sciences Inc. has provided an update on its Phase III clinical program evaluating Urocidin(TM) in the treatment of bladder cancer. On March 31st, the Company announced that recruitment had been completed in its initial Phase III registration trial evaluating Urocidin in the treatment of non-muscle-invasive bladder cancer that is refractory (unresponsive) to the current standard immunotherapy - Bacillus Calmette-Guérin (BCG).
An estimated 600 experts on nanobiotechnology-a science that develops tools and machinery at the scale of one-billionth of a meter-are expected to attend the second annual Johns Hopkins NanoBio Symposium, May 1-2, 2008.
› Verified 6 days ago
Dr. Keri Lynn Crewson, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: Sanford Health, 801 Broadway North, Fargo, ND 58122 Phone: 701-234-5933 Fax: 701-234-7230 | |
Abdallah M Mansour, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 3000 32nd Ave S, Fargo, ND 58103 Phone: 701-364-8900 | |
Derek Anderson, DO Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 5225 23rd Ave S, Fargo, ND 58104 Phone: 701-234-5933 | |
Gerald G Gross, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 820 4th St N, Fargo, ND 58102 Phone: 701-234-6161 | |
Paul James Carson, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-4811 Fax: 701-234-6979 | |
Howard L Russell, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 820 N 4th St, Fargo, ND 58122 Phone: 701-234-6161 Fax: 701-234-3861 | |
Dr. Emuejevoke Joseph Okoh, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-2000 |